May 13, 2015 – Fujifilm Medical Systems U.S.A. said it completed its acquisition of TeraMedica Inc., a global healthcare informatics company and a provider of vendor neutral, enterprise solutions. The acquisition will allow Fujifilm to offer the market a leading vendor neutral archiving (VNA) technology.
“As a leader in clinical archiving, TeraMedica is at the forefront of the vendor neutral archive market. It is a company with talented people and unique technology that will strengthen our position in healthcare informatics,” said Jim Morgan, Fujifilm vice president of medical informatics. “Together, we will be able to deliver medical informatics solutions that acquire, analyze, interpret and present patient data in ways that are meaningful for providers in the most challenging environments.”
TeraMedica recently received the "VNA/Image Archive KLAS Category Leader" Award for 2014 as part of the Best in KLAS Report. The company enables cross-departmental image content sharing of patient data from disparate healthcare IT applications, while always maintaining the integrity of the original data stored while also embracing the latest centralized archiving technologies.
Today, VNA technology serves a growing number of forward-thinking healthcare enterprises around the world to realize the promise of truly integrated patient-centric healthcare. Achieving this across multiple health care applications as well as IT systems and providers, it plays a crucial role in placing healthcare enterprises on the road to meaningful use.
The combined company will now be known as Fujifilm TeraMedica Inc.
“The VNA market is expected to see significant growth in the coming years, and now with the combined strength of Fujifilm Medical Systems, we have the ability to meet this demand,” said Jim Prekop, president and CEO, Fujifilm TeraMedica Inc. “This transaction will bring together the complementary strengths of Fujifilm’s best-in-class software and services with TeraMedica’s pioneering VNA, maximizing our operational efficiencies.”
April 11, 2024 
